Carfilzomib BOS 60 mg Powder for Solution for Injection/Infusion

Carfilzomib BOS 60 mg is a specialized prescription medication formulated as a powder for solution for injection or infusion.
It contains Carfilzomib, an advanced proteasome inhibitor used in the treatment of specific types of multiple myeloma.
This medication is critical for patients requiring targeted therapy to manage their condition.
Available through leading online pharmacies and platforms like Nahdi Online, , and , Carfilzomib BOS provides an essential treatment option.

Benefits of Use

• Targeted therapy for multiple myeloma: Carfilzomib selectively inhibits proteasomes in cancer cells, leading to their death and slowing disease progression.
• Effective in relapsed or refractory multiple myeloma: It is often used in patients who have not responded to or have relapsed after previous treatments.
• Part of a comprehensive treatment regimen: Can be used alone or in combination with other medications as prescribed by your oncologist.

How to Use

Carfilzomib BOS 60 mg Powder for Solution for Injection/Infusion is a complex medication that must be administered by a qualified healthcare professional in a clinical setting.

1. Your healthcare provider will reconstitute the powder with sterile water for injection according to the manufacturer’s instructions.
2. The reconstituted solution will then be further diluted into an intravenous solution (e.g., 0.9% sodium chloride or 5% dextrose).
3. It is administered via intravenous infusion over a specified period, typically 10 to 30 minutes, depending on the dose and treatment cycle.
4. The frequency and duration of treatment will be determined by your doctor based on your specific condition, response to therapy, and tolerability.
5. Always ensure you attend all scheduled appointments for administration and follow-up.

Caution & Warnings

• This medication must only be administered by a healthcare professional experienced in oncology treatment.
• Serious and sometimes fatal cardiac, pulmonary, and renal toxicities have been reported. Regular monitoring of cardiac function, blood pressure, and renal function is essential.
• Infusion-related reactions, including fever, chills, arthralgia, myalgia, facial flushing, facial edema, laryngeal pain, and chest tightness, may occur.
• Thrombocytopenia (low platelet count) is a common side effect, requiring regular blood count monitoring.
• Risk of hepatic toxicity; liver function tests should be monitored periodically.
• Peripheral neuropathy has been reported.
• Patients should be adequately hydrated before and after administration to reduce the risk of renal toxicity.
• Inform your doctor about all other medications, supplements, and herbal products you are taking, as drug interactions can occur.
• Not recommended for use during pregnancy or breastfeeding due to potential harm to the fetus or infant. Effective contraception must be used by women of childbearing potential during treatment and for a specified period after.

Ingredients

• Active Ingredient: Carfilzomib 60 mg
• Excipients: Common excipients for lyophilized powders may include cyclodextrins (e.g., sulfobutylether beta-cyclodextrin), citric acid, sodium citrate, and mannitol to aid solubility and stability. Exact excipients are listed in the product's official prescribing information.

Product Details

• Drug Type: Prescription Medication (Proteasome Inhibitor)
• Form: Powder for solution for injection/infusion
• Strength: 60 mg
• Administration Route: Intravenous
• Package Size: 1 Vial
• Brand: Carfilzomib BOS